One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Hemodialysis Market

[ 英語タイトル ] Hemodialysis Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0089127
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 112
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- Cantel Medical Corp.
- DaVita Inc.
- Fresenius Medical Care AG & Co. KGaA
- Medtronic PLC
- Nipro Corporation
- NxStage Medical, Inc.

[Report Description]

The major factors for the growth of the hemodialysis market include the rising number of end-stage renal disease (ESRD) patients and the increasing incidence of diabetes and hypertension.

The rise in the number of ESRD and shortage in the availability of kidneys for transplant expected to boost the growth of the market. Chronic kidney disease (CKD) is a condition that causes reduced kidney function over a period of time. It may develop over many years and lead to end-stage kidney (or renal) disease (ESRD). It has become an enormous public health issue that continues to rise.

As per the estimation by the Global Burden of Disease Study, kidney disease was the 12th-most common cause of death, accounting for 1.1 million deaths worldwide in 2015. Furthermore, as per the 2016 report on Diabetes and Chronic Kidney Disease, Diabetes causes 44% of all new cases of kidney failure. Thus, owing to the rising burden of kidney failures there will be a huge demand for hemodialysis equipment resulting in high growth of the market.

Key Market Trends

Conventional Long-Term Hemodialysis is the Segment by Modality expected to hold Largest Market Share over the Forecast Period

The hemodialysis market is segmented by Modality in three major segments Conventional Long-Term Hemodialysis, Short Daily Hemodialysis, and Nocturnal hemodialysis. The Conventional Long-Term Hemodialysis is expected to hold a large market share owing to the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients.

According to the Organ Procurement and Transplantation Network around 83.7% of people are waiting for kidney transplants. Thus, owing to the shortage of kidneys for transplant the market is expected to witness high growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest market for hemodialysis owing to the presence of better healthcare infrastructure and the presence of major market players. As per the Center for disease control and prevention, 15% of US adults or 37 million people are estimated to have chronic kidney disease common in people aged 65 years or older (38%) than in people aged 45–64 years (13%) or 18–44 years.

According to the Population Reference Bureau, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. An aging population and growing risk of chronic kidney disease projected to significantly boost regional growth.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of few market players. Some of the market players are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cantel Medical Corp., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic PLC, Nipro Corporation, and NxStage Medical, Inc.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Number of End Stage Renal Disease Patients
4.2.2 Increasing Incidence of Diabetes and Hypertension
4.3 Market Restraints
4.3.1 Risks and Complications associated with Dialysis
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product Type
5.1.1 Equipment Dialysis Machines Hemodialysis Water Treatment Systems Others hemodialysis equipment
5.1.2 Consumables Dialyzers Catheters Other hemodialysis consumables
5.2 By Modality
5.2.1 Conventional Long-Term Hemodialysis
5.2.2 Short Daily Hemodialysis
5.2.3 Nocturnal hemodialysis
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Asahi Kasei Corporation
6.1.2 B. Braun Melsungen AG
6.1.3 Baxter International Inc.
6.1.4 Becton, Dickinson and Company
6.1.5 Cantel Medical Corp.
6.1.6 DaVita Inc.
6.1.7 Fresenius Medical Care AG & Co. KGaA
6.1.8 Medtronic PLC
6.1.9 Nipro Corporation
6.1.10 NxStage Medical, Inc.




Recommended reports